Provided herein are methods of treating (e.g., inhibiting, modulating, reversing, or reducing the severity of at least one symptom of) a dysbiosis in a subject, the method comprising administering an effective amount of a composition described herein (e.g., a composition comprising polyglucosamine-arginine (PAAG)).

Provided herein are methods of treating (e.g., inhibiting, modulating, reversing, or reducing the severity of at least one symptom of) a dysbiosis in a subject, the method comprising administering an effective amount of a composition described herein (e.g., a composition comprising polyglucosamine-arginine (PAAG)).

The use of powdered or gelled hypochlorous acid (HOCI) in the treatment or prevention of viral and bacterial infection is disclosed.

A system and method and apparatus comprising an anti-microbial, self-adhesive film, are provided which prevents dirt, sweat, fungus, and bacteria, from absorbing into the insole and the sides and bottoms of the insole. The antimicrobial, self-adhesive film of the invention is provided in a size suitable for application to an insole so as to prevent dirt, sweat, bacteria, foot wort fungus etc. from absorbing into an insole and sides, to and bottom areas of said insole.

A system and method and apparatus comprising an anti-microbial, self-adhesive film, are provided which prevents dirt, sweat, fungus, and bacteria, from absorbing into the insole and the sides and bottoms of the insole. The antimicrobial, self-adhesive film of the invention is provided in a size suitable for application to an insole so as to prevent dirt, sweat, bacteria, foot wort fungus etc. from absorbing into an insole and sides, to and bottom areas of said insole.

Natural polymer-based fibrous elements including a modified polymer derived from a natural polymer and a surfactant, method for making such natural polymer-based fibrous elements and methods for making such fibrous structures are provided.

A control system and pathogen inactivation method to reduce cross-contamination within operational devices that experience sequential touching of touch spots on the operational device by multiple people. Additionally, the system controls and then executes the reconfiguration of touch spot position to increase the probabilistic time interval between sequential touches from a first person to a second person physically interacting with the operational device. The dynamic reconfiguration control system reduces the probability of cross-contamination between sequential personal touches in sequential user sessions.

A control system and pathogen inactivation method to reduce cross-contamination within operational devices that experience sequential touching of touch spots on the operational device by multiple people. Additionally, the system controls and then executes the reconfiguration of touch spot position to increase the probabilistic time interval between sequential touches from a first person to a second person physically interacting with the operational device. The dynamic reconfiguration control system reduces the probability of cross-contamination between sequential personal touches in sequential user sessions.

The invention relates to highly effective disinfecting or sterilising cloths with chlorine dioxide as the main active ingredient. For this, the chlorine dioxide is only generated shortly before use by bringing a cloth impregnated with a chlorite or chlorate salt in contact with a clearly defined amount of a suitable activation agent that is fluid or dissolved or admixed in a fluid, and prepackaged as a single dose, for the generation of chlorine dioxide. In a preferred embodiment, the impregnated cloth and the activation fluid are packaged in a common packaging unit and the activation occurs by breaking through a barrier separating the cloth or the cloths and the activation fluid. In a further preferred embodiment, the packaging is a moulded part having two packaging spaces separated from one another by removable barriers, which can be converted into a moulded part with only one chamber via simple pressure in one direction. The activation fluid or the disinfecting cloth can contain further substances, such as the pH-value-controlling substances, surfactants, guanidine derivatives, aldehydes, phenoxyethanols, phosphate esters, alcohols, sulfoxides, etc. Preferably, the disinfecting cloth according to the invention is used for disinfecting and/or sterilising medical instruments and/or medical products and/or surfaces.

The invention relates to highly effective disinfecting or sterilising cloths with chlorine dioxide as the main active ingredient. For this, the chlorine dioxide is only generated shortly before use by bringing a cloth impregnated with a chlorite or chlorate salt in contact with a clearly defined amount of a suitable activation agent that is fluid or dissolved or admixed in a fluid, and prepackaged as a single dose, for the generation of chlorine dioxide. In a preferred embodiment, the impregnated cloth and the activation fluid are packaged in a common packaging unit and the activation occurs by breaking through a barrier separating the cloth or the cloths and the activation fluid. In a further preferred embodiment, the packaging is a moulded part having two packaging spaces separated from one another by removable barriers, which can be converted into a moulded part with only one chamber via simple pressure in one direction. The activation fluid or the disinfecting cloth can contain further substances, such as the pH-value-controlling substances, surfactants, guanidine derivatives, aldehydes, phenoxyethanols, phosphate esters, alcohols, sulfoxides, etc. Preferably, the disinfecting cloth according to the invention is used for disinfecting and/or sterilising medical instruments and/or medical products and/or surfaces.